Amounts, Activities, Absorbed Doses, and BEDs
| Optimal for kidney BED 20* Gy2.5, red marrow BED < 1 Gy15 | Actually administered | ||||||||
| Patient no. | Data | Tumor | Amount (nmol) | Activity (MBq) | Tumor D (Gy) (BED [Gy10]) | Amount (nmol) | Activity (MBq) | Tumor D (Gy) (BED [Gy10]) | Kidney D† (Gy) (BED [Gy2.5]) |
| P1 | N1 | 1 | 64 | 4,083 | 19 (20) | 47 | 3,850 | 20 (21) | 16 (22) |
| 2 | 32 | 2,954 | 10 (11) | 11 (12) | |||||
| N2 | 1 | 128 | 4,760 | 17 (18) | 70 | 5,430 | 27 (29) | 23 (36) | |
| 2 | 64 | 3,191 | 9.0 (10) | 15 (15) | |||||
| N3 | 1 | 128 | 5,073 | 18 (19) | 57 | 5,000 | 20 (21) | 16 (22) | |
| 2 | 64 | 3,379 | 12 (13) | 13 (14) | |||||
| P2 | N4 | 1 | 128 | 7,574 | 39 (44) | 73 | 4,010 | 38 (43) | 14 (20) |
| N5 | 1 | 128 | 6,718 | 33 (37) | 55 | 2,560 | 19 (20) | 9.2 (11) | |
| P3 | N6 | 1 | 2† | 1,606 | 4.3 (4.4) | — | — | — | — |
| 2 | 32 | 2,591 | 30 (33) | ||||||
| P4 | N7 | 1 | 64 | 4,342 | 25 (28) | 70 | 5,360 | 30 (33) | 16 (24) |
| P5 | N8 | 1 | 128 | 6,217 | 67 (74) | — | — | — | — |
| P6 | N9 | 1 | 32 | 2,674 | 19 (20) | 70 | 4,000 | 19 (20) | 15 (21) |
| 2 | 32 | 2,681 | 47 (53) | 48 (54) | |||||
| P7 | N10 | 1 | 128 | 9,596 | 51 (55) | — | — | — | — |
| 2 | 128 | 9,596 | 29 (30) | ||||||
| P8 | N11 | 1 | 64 | 4,915 | 57 (61) | — | — | — | — |
| 2 | 16 | 2,924 | 113 (133) | ||||||
| P9 | N12 | 1 | 128 | 3,665 | 11 (11) | — | — | — | — |
| 2 | 128 | 3,664 | 7.7 (7.8) | ||||||